SCHEMBL30234364

SCHEMBL30234364

Cc1cc(Nc2ccc(NC(=O)c3cn(C)c4ccccc34)cc2)nc(N2CCCC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 5/20 0.48
▸ CDK2 P24941 5/20 0.48
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MAOB P27338 2/20 0.46
▸ HTR2C P28335 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ GALR2 O43603 3/20 0.43
▸ GALR1 P47211 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CSF1R P07333 1/20 0.42
▸ DNMT1 P26358 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867526 1.00 CCNE1 (0.48) CCNE1CDK2LMNAMAPTMAOB
SCHEMBL30165660 0.85 CCNE1 (0.43) CCNE1CDK2LMNAMAPTKDM4E
SCHEMBL23867488 0.82 LMNA (0.42) CCNE1CDK2LMNAMAPTKDM4E
SCHEMBL23859943 0.81 HRH3 (0.53) CCNE1CDK2LMNAMAPTHTR2C
SCHEMBL30165658 0.81 HRH3 (0.53) CCNE1CDK2LMNAMAPTHTR2C
SCHEMBL30234371 0.78 ROCK1 (0.46) CCNE1CDK2LMNAMAPTKDM4E
SCHEMBL11506640 0.75 GALR2 (0.66) LMNAMAPTKDM4EGALR2GALR1
SCHEMBL31094236 0.74 CCNE1 (0.47) CCNE1CDK2LMNAMAPTKDM4E
SCHEMBL23867469 0.74 CCNE1 (0.45) CCNE1CDK2LMNAMAPTKDM4E
SCHEMBL23867651 0.74 LMNA (0.53) CCNE1CDK2LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118338898-A Small molecule inhibitors of oncogenic CHD1L with preclinical anti-colorectal cancer activity 科罗拉多州立大学董事会(法人团体) 2024-07-12 — — CN disclosed
WO-2023055763-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTRAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-04-06 — — WO disclosed
Send feedback